0001752724-22-269122.txt : 20221128 0001752724-22-269122.hdr.sgml : 20221128 20221128110854 ACCESSION NUMBER: 0001752724-22-269122 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221128 DATE AS OF CHANGE: 20221128 PERIOD START: 20221231 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Morgan Stanley Insight Fund CENTRAL INDEX KEY: 0001002427 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-07377 FILM NUMBER: 221422283 BUSINESS ADDRESS: STREET 1: C/O MORGAN STANLEY STREET 2: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 800-548-7786 MAIL ADDRESS: STREET 1: C/O MORGAN STANLEY STREET 2: 522 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: MORGAN STANLEY MULTI CAP GROWTH TRUST DATE OF NAME CHANGE: 20110331 FORMER COMPANY: FORMER CONFORMED NAME: MORGAN STANLEY CAPITAL OPPORTUNITIES TRUST DATE OF NAME CHANGE: 20020129 FORMER COMPANY: FORMER CONFORMED NAME: MORGAN STANLEY MID CAP EQUITY TRUST DATE OF NAME CHANGE: 20010618 0001002427 S000002337 Morgan Stanley Insight Fund C000006127 A CPOAX C000006129 L CPOCX C000006130 I CPODX C000126925 CLASS IS MCRTX C000155915 Class C MSCMX C000216311 Class IR NPORT-P 1 primary_doc.xml NPORT-P false 0001002427 XXXXXXXX S000002337 C000216311 C000155915 C000006127 C000126925 C000006130 C000006129 Morgan Stanley Insight Fund 811-07377 0001002427 54930088ZHK6FN0CHD61 522 FIFTH AVENUE NEW YORK 10036 800-548-7786 Morgan Stanley Insight Fund S000002337 54930088ZHK6FN0CHD61 2022-12-31 2022-09-30 N 1909811291.74 43086439.07 1866724852.67 0.00000000 16406289.83000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 UST Securities Portfolio SEC_PORT Goldman Sachs & Co. LLC FOR8UP27PHTHYVLBNG30 CNHP21132 USD CALL CNH PUT 000000000 1670325800.09000000 OU Notional Amount USD 8555408.75000000 0.458311182698 N/A DFE US N 2 Goldman Sachs & Co. LLC FOR8UP27PHTHYVLBNG30 Call Purchased Goldman Sachs & Co. LLC FOR8UP27PHTHYVLBNG30 Goldman Sachs & Co. LLC FOR8UP27PHTHYVLBNG30 FX Contract N/A 1.00000000 NC USD 8555408.75000000 0.46000000 DFE US 12143268567.00000000 CNY 1670325800.00000000 USD 2022-11-10 1.00000000 7.27000000 USD 2022-11-10 XXXX 536817.66000000 N N N 10X Genomics Inc 5493003Z6741WNLG7H43 10X Genomics Inc 88025U109 753317.00000000 NS USD 21454468.16000000 1.149310683323 Long EC CORP US N 1 N N N HSBC Securities (USA) Inc. CYYGQCGNHMHPSMRL3R97 HSBC TRI PARTY A REPO 000000000 2390680.76894945 PA USD 2390680.76894945 0.128068192027 Long RA CORP US N 2 Repurchase Y 2.97000000 2022-10-03 2511410.14778100 USD 2438503.91119131 USD UST N N SWAP CITIBANK BOC N/A SWAP CITIBANK BOC 000000000 -8280000.00000000 NS USD -8280000.00000000 -0.44355760240 Short STIV CORP US N 2 N N N Merrill Lynch, Pierce, Fenner & Smith Incorporated 8NAV47T0Y26Q87Y0QP81 MERRILL LYNCH TRI PARTY A REPO 000000000 717204.23068483 PA USD 717204.23068483 0.038420457608 Long RA CORP US N 2 Repurchase Y 2.95000000 2022-10-03 799515.36956000 USD 731554.05890908 USD UST N N JPMorgan Securities LLC ZBUT11V806EZRVTWT807 CNHP12666 USD CALL CNH PUT 000000000 456541098.89000000 OU Notional Amount USD 4215700.51000000 0.225834059260 N/A DFE US N 2 JPMorgan Securities LLC ZBUT11V806EZRVTWT807 Call Purchased JPMorgan Securities LLC ZBUT11V806EZRVTWT807 JPMorgan Securities LLC ZBUT11V806EZRVTWT807 FX Contract N/A 1.00000000 NC USD 4215700.51000000 0.23000000 DFE US 3437754475.00000000 CNY 456541098.90000000 USD 2023-07-21 1.00000000 7.53000000 USD 2023-07-21 XXXX 1948973.95000000 N N N agilon health Inc N/A agilon health Inc 00857U107 4738988.00000000 NS USD 110987098.96000000 5.945552115045 Long EC CORP US N 1 N N N Cloudflare Inc 5493007DY18BGNLDWU14 Cloudflare Inc 18915M107 2007941.00000000 NS USD 111059216.71000000 5.949415445514 Long EC CORP US N 1 N N N Uber Technologies Inc 549300B2FTG34FILDR98 Uber Technologies Inc 90353T100 4045781.00000000 NS USD 107213196.50000000 5.743385070737 Long EC CORP US N 1 N N N Sea Ltd 529900OM6JLLW44YKI15 Sea Ltd 81141R100 373455.00000000 NS USD 20932152.75000000 1.121330372821 Long EC CORP KY N 1 N N N Aurora Innovation Inc N/A Aurora Innovation Inc 051774107 2489360.00000000 NS USD 5501485.60000000 0.294713256328 Long EC CORP US N 1 N N N Bill.com Holdings Inc 549300IBF9VZZIGOZW63 Bill.com Holdings Inc 090043100 707043.00000000 NS USD 93591281.91000000 5.013662392512 Long EC CORP US N 1 N N N Carvana Co 5493003WEAK2PJ5WS063 Carvana Co 146869102 602480.00000000 NS USD 12230344.00000000 0.655176577442 Long EC CORP US N 1 N N N ZoomInfo Technologies Inc N/A ZoomInfo Technologies Inc 98980F104 1156492.00000000 NS USD 48179456.72000000 2.580961872934 Long EC CORP US N 1 N N N Wayfair Inc 54930027N9ZAVYFDHK53 Wayfair Inc 94419L101 453192.00000000 NS USD 14751399.60000000 0.790228917716 Long EC CORP US N 1 N N N Intellia Therapeutics Inc 5493002T5BCPE5DZC723 Intellia Therapeutics Inc 45826J105 200038.00000000 NS USD 11194126.48000000 0.599666654889 Long EC CORP US N 1 N N N ASML Holding NV 724500Y6DUVHQD6OXN27 ASML Holding NV 000000000 96179.00000000 NS USD 39947947.65000000 2.140001917950 Long EC CORP NL Y 1 N N N Block Inc 549300OHIIUWSTIZME52 Block Inc 852234103 438754.00000000 NS USD 24127082.46000000 1.292481986592 Long EC CORP US N 1 N N N Veeva Systems Inc 549300YZEXPDB92M2F02 Veeva Systems Inc 922475108 113753.00000000 NS USD 18755594.64000000 1.004732679975 Long EC CORP US N 1 N N N Trade Desk Inc/The 549300GXPD31VT3E0P46 Trade Desk Inc/The 88339J105 2047549.00000000 NS USD 122341052.75000000 6.553780680372 Long EC CORP US N 1 N N N Moderna Inc 549300EI6OKH5K5Q2G38 Moderna Inc 60770K107 45392.00000000 NS USD 5367604.00000000 0.287541251316 Long EC CORP US N 1 N N N Coupang Inc 549300XR4L1D80AK4W76 Coupang Inc 22266T109 2640881.00000000 NS USD 44023486.27000000 2.358327538578 Long EC CORP US N 1 N N N Adyen NV 724500973ODKK3IFQ447 Adyen NV 000000000 44230.00000000 NS 55161945.97000000 2.955012137493 Long EC CORP NL Y 2 N N N Morgan Stanley & Co. LLC 549300OJY9IZ31SGS926 Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio 61747C525 26707950.21000000 NS USD 26707950.21000000 1.430738449311 Long STIV RF US N 1 N N N SWAP GOLDMAN SACHS BOC N/A SWAP GOLDMAN SACHS BOC 000000000 -631000.00000000 NS USD -631000.00000000 -0.03380251776 Short STIV CORP US N 2 N N N Doximity Inc N/A Doximity Inc 26622P107 1860392.00000000 NS USD 56221046.24000000 3.011747883443 Long EC CORP US N 1 N N N MongoDB Inc 549300TPTG69WKWE1Z37 MongoDB Inc 60937P106 126492.00000000 NS USD 25116251.52000000 1.345471534494 Long EC CORP US N 1 N N N Guardant Health Inc 254900M8C3E5VC8BR186 Guardant Health Inc 40131M109 375153.00000000 NS USD 20194485.99000000 1.081813742454 Long EC CORP US N 1 N N N Cipher Mining Inc N/A Cipher Mining Inc 17253J106 3039698.00000000 NS USD 3830019.48000000 0.205173219530 Long EC CORP US N 1 N N N Ginkgo Bioworks Holdings Inc N/A Ginkgo Bioworks Holdings Inc 37611X100 3540003.00000000 NS USD 11044809.36000000 0.591667772794 Long EC CORP US N 1 N N DoorDash Inc 549300NUQ43FGGSK5051 DoorDash Inc 25809K105 1385283.00000000 NS USD 68502244.35000000 3.669648703290 Long EC CORP US N 1 N N N MAGIC LEAP CL A COMMON N/A MAGIC LEAP CL A COMMON 000000000 3889.00000000 NS USD 0.00000000 0.000000 Long EC CORP US N 3 N N N LOOKOUT INC SER F CVT PFD PP N/A LOOKOUT INC SER F CVT PFD PP 000000000 197427.00000000 NS USD 959495.22000000 0.051399927451 Long EP CORP US N 3 N N N Affirm Holdings Inc N/A Affirm Holdings Inc 00827B106 890447.00000000 NS USD 16704785.72000000 0.894871340899 Long EC CORP US N 1 N N N Heliogen Inc N/A Heliogen Inc 42329E105 3097525.00000000 NS USD 5761396.50000000 0.308636620536 Long EC CORP US N 1 N N N Snowflake Inc 254900CJNSY1K7T53Z16 Snowflake Inc 833445109 850167.00000000 NS USD 144494383.32000000 7.740529254395 Long EC CORP US N 1 N N N Gitlab Inc N/A Gitlab Inc 37637K108 543119.00000000 NS USD 27818555.18000000 1.490233289614 Long EC CORP US N 1 N N N MicroStrategy Inc 549300WQTWEJUEHXQX21 MicroStrategy Inc 594972408 41066.00000000 NS USD 8716669.16000000 0.466949863957 Long EC CORP US N 1 N N ProKidney Corp N/A ProKidney Corp 000000000 1421688.00000000 NS USD 12809408.88000000 0.686196943361 Long EC CORP KY N 1 N N N Datadog Inc 549300F6JNO0KRPO1K63 Datadog Inc 23804L103 977226.00000000 NS USD 86758124.28000000 4.647611786809 Long EC CORP US N 1 N N N Global-e Online Ltd N/A Global-e Online Ltd 000000000 905928.00000000 NS USD 24242633.28000000 1.298672016142 Long EC CORP IL N 1 N N N Shopify Inc 549300HGQ43STJLLP808 Shopify Inc 82509L107 2751353.00000000 NS USD 74121449.82000000 3.970668184654 Long EC CORP CA N 1 N N N Peloton Interactive Inc 5493002YS021166W0339 Peloton Interactive Inc 70614W100 1974721.00000000 NS USD 13684816.53000000 0.733092319975 Long EC CORP US N 1 N N N Unity Software Inc 549300D1ESJMGNQNG432 Unity Software Inc 91332U101 566892.00000000 NS USD 18061179.12000000 0.967533008100 Long EC CORP US N 1 N N N Grayscale Bitcoin Trust BTC 549300XZGUJEF0EHBE41 Grayscale Bitcoin Trust BTC 389637109 1186156.00000000 NS USD 13534039.96000000 0.725015255496 Long EC RF US N 1 N N N ROBLOX Corp N/A ROBLOX Corp 771049103 2414982.00000000 NS USD 86552954.88000000 4.636620911550 Long EC CORP US N 1 N N N SWAP JP MORGAN BOC N/A SWAP JP MORGAN BOC 000000000 -4050000.00000000 NS USD -4050000.00000000 -0.21695752291 Short STIV CORP US N 2 N N N Standard Chartered Bank RILFO74KP1CM8P6PCT96 CNHP60034 USD CALL/CNH PUT 000000000 488704357.63000000 OU Notional Amount USD 4499989.73000000 0.241063364189 N/A DFE US N 2 Standard Chartered Bank RILFO74KP1CM8P6PCT96 Call Purchased Standard Chartered Bank RILFO74KP1CM8P6PCT96 Standard Chartered Bank RILFO74KP1CM8P6PCT96 FX Contract N/A 1.00000000 NC USD 4499989.73000000 0.24000000 DFE US 3699003283.00000000 CNY 488704357.60000000 USD 2023-08-23 1.00000000 7.56900000 USD 2023-08-23 XXXX 2318413.48000000 N N N Morgan Stanley & Co. LLC 549300OJY9IZ31SGS926 Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio 61747C525 16854299.42826570 NS USD 16854299.42826570 0.902880754180 Long STIV RF US N 1 N N Rivian Automotive Inc N/A Rivian Automotive Inc 76954A103 309230.00000000 NS USD 10176759.30000000 0.545166540502 Long EC CORP US N 1 N N N MercadoLibre Inc 549300DKPDN9M5S8GB14 MercadoLibre Inc 58733R102 50188.00000000 NS USD 41544622.64000000 2.225535411958 Long EC CORP US N 1 N N N DATABRICKS, INC. N/A DATABRICKS, INC. 000000000 761973.00000000 NS USD 45383111.88000000 2.431162354488 Long EP CORP US N 3 N N N SWAP STAND. CHARTER BANK BOCOC N/A SWAP STAND. CHARTER BANK BOCOC 000000000 -5390000.00000000 NS USD -5390000.00000000 -0.28874099963 Short STIV CORP US N 2 N N N Ginkgo Bioworks Holdings Inc N/A Ginkgo Bioworks Holdings Inc 37611X118 343913.00000000 NS USD 247617.36000000 0.013264802236 N/A DE US N 1 N/A N/A Call Purchased Ginkgo Bioworks Holdings Inc Ginkgo Bioworks Holdings Inc 11.50000000 11.50000000 USD 2027-12-31 XXXX -897612.93000000 N N N Royalty Pharma PLC 549300FGFN7VOK8BZR03 Royalty Pharma PLC 000000000 2715269.00000000 NS USD 109099508.42000000 5.844434345209 Long EC CORP GB N 1 N N N Coinbase Global Inc 5493004G3J2SC154DU06 Coinbase Global Inc 19260Q107 260096.00000000 NS USD 16773591.04000000 0.898557225292 Long EC CORP US N 1 N N Grab Holdings Limited 549300N4VQX83VPJF439 Grab Holdings Limited 000000000 9629695.00000000 NS USD 25326097.85000000 1.356712951765 Long EC CORP KY N 1 N N N Upstart Holdings Inc 549300WNB47JRNENIC75 Upstart Holdings Inc 91680M107 162839.00000000 NS USD 3385422.81000000 0.181356283180 Long EC CORP US N 1 N N 2022-10-25 Morgan Stanley Insight Fund Francis Smith Francis Smith Principal Financial Officer XXXX NPORT-EX 2 NPORT_MGCD_36433402_0922.htm

 

Morgan Stanley Insight Fund

Consolidated Portfolio of Investments ▪ September 30, 2022 (unaudited)

 

  
NUMBER OF
SHARES
      VALUE 
    Common Stocks (95.3%)     
    Automobiles (0.5%)     
309,230   Rivian Automotive, Inc., Class A (a)  $10,176,759 
          
    Biotechnology (1.6%)     
200,038   Intellia Therapeutics, Inc. (a)   11,194,126 
45,392   Moderna, Inc. (a)   5,367,604 
1,421,688   ProKidney Corp. (a)   12,809,409 
        29,371,139 
    Capital Markets (0.9%)     
260,096   Coinbase Global, Inc., Class A (a)(b)   16,773,591 
          
    Chemicals (0.6%)     
3,540,003   Ginkgo Bioworks Holdings, Inc. (a)(b)   11,044,809 
          
    Commercial Services & Supplies (0.3%)     
2,489,360   Aurora Innovation, Inc. (a)   5,501,486 
          
    Consumer Finance (0.2%)     
162,839   Upstart Holdings, Inc. (a)(b)   3,385,423 
          
    Electrical Equipment (0.3%)     
3,097,525   Heliogen, Inc. (a)   5,761,397 
          
    Electronic Equipment, Instruments & Components (0.0%)     
3,889   Magic Leap, Class A (a)(c)(d) (acquisition cost — $1,890,214; acquired 12/22/15)    
          
    Entertainment (5.8%)     
2,414,982   ROBLOX Corp., Class A (a)   86,552,955 
373,455   Sea Ltd. ADR (a)   20,932,153 
        107,485,108 
    Health Care Providers & Services (7.0%)     
4,738,988   Agilon health, Inc. (a)   110,987,099 
375,153   Guardant Health, Inc. (a)   20,194,486 
        131,181,585 
    Health Care Technology (4.0%)     
1,860,392   Doximity, Inc., Class A (a)   56,221,046 
113,753   Veeva Systems, Inc., Class A (a)   18,755,595 
        74,976,641 
    Information Technology Services (24.2%)     
44,019   Adyen NV (a)   54,898,795 
890,447   Affirm Holdings, Inc. (a)   16,704,786 
438,754   Block, Inc., Class A (a)   24,127,082 
2,007,941   Cloudflare, Inc., Class A (a)   111,059,217 
126,492   MongoDB, Inc. (a)   25,116,251 
2,751,353   Shopify, Inc., Class A (a)   74,121,450 
850,167   Snowflake, Inc., Class A (a)   144,494,383 
        450,521,964 
    Interactive Media & Services (2.6%)     
1,156,492   ZoomInfo Technologies, Inc., Class A (a)   48,179,457 
          
    Internet & Direct Marketing Retail (10.4%)     
2,640,881   Coupang, Inc. (a)   44,023,486 
1,385,283   DoorDash, Inc., Class A (a)   68,502,244 
925,057   Global-e Online Ltd. (a)   24,754,525 
50,188   MercadoLibre, Inc. (a)   41,544,623 
453,192   Wayfair, Inc., Class A (a)   14,751,400 
        193,576,278 
    Leisure Products (0.7%)     
1,974,721   Peloton Interactive, Inc., Class A (a)   13,684,817 

 

 

  

Morgan Stanley Insight Fund

Consolidated Portfolio of Investments ▪ September 30, 2022 (unaudited) continued

 

    Life Sciences Tools & Services (1.1%)    
 753,317   10X Genomics, Inc., Class A (a)   21,454,468 
           
     Pharmaceuticals (5.8%)     
 2,715,269   Royalty Pharma PLC, Class A (United Kingdom)   109,099,508 
           
     Road & Rail (7.1%)     
 9,629,695   Grab Holdings Ltd., Class A (a)   25,326,098 
 4,045,781   Uber Technologies, Inc. (a)   107,213,196 
         132,539,294 
     Semiconductors & Semiconductor Equipment (2.1%)     
 96,179   ASML Holding NV   39,947,948 
           
     Software (19.4%)     
 707,043   Bill.Com Holdings, Inc. (a)   93,591,282 
 3,039,698   Cipher Mining, Inc. (a)   3,830,020 
 977,226   Datadog, Inc., Class A (a)   86,758,124 
 543,119   Gitlab, Inc., Class A (a)   27,818,555 
 41,066   MicroStrategy, Inc., Class A (a)(b)   8,716,669 
 2,047,549   Trade Desk, Inc., Class A (a)   122,341,053 
 566,892   Unity Software, Inc. (a)   18,061,179 
         361,116,882 
     Specialty Retail (0.7%)     
 602,480   Carvana Co. (a)   12,230,344 
     Total Common Stocks (Cost $2,986,215,583)   1,778,008,898 

 

NUMBER OF
WARRANTS
           
        Warrant (0.0%) (e)        
        Chemicals (0.0%) (e)        
  343,913     Ginkgo Bioworks Holdings, Inc. expires 12/31/27 (a) (Cost $1,145,230)     247,617  

 

NUMBER OF
SHARES
       
    Preferred Stocks (2.5%)    
    Software (2.5%)
 253,991   Databricks, Inc.(a)(c)(d) (acquisition cost — $55,992,926; acquired 8/31/21)   45,383,112 
 197,427   Lookout, Inc., Series F (a)(c)(d) (acquisition cost — $2,255,228; acquired 6/17/14)   959,495 
     Total Preferred Stocks (Cost $58,248,154)   46,342,607 
           
     Investment Company (0.7%)     
 1,186,156   Grayscale Bitcoin Trust (a)(Cost $48,421,120)   13,534,040 

 

NUMBER OF
SHARES
(000)
        
     Short-Term Investments (2.5%)     
     Securities held as Collateral on Loaned Securities (1.1%)     
     Investment Company (0.9%)     
 16,854   Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - Institutional Class (f)   16,854,300 

 

PRINCIPAL
AMOUNT
(000)
        
     Repurchase Agreements (0.2%)     
$2,391   HSBC Securities USA, Inc. (2.97%, dated 9/30/22, due 10/3/22; proceeds $2,391,272; fully collateralized by a U.S. Government obligation; 0.00% due 7/13/23; valued at $2,438,504)     2,390,681 
 717   Merrill Lynch & Co., Inc. (2.95%, dated 9/30/22, due 10/3/22; proceeds $717,381; fully collateralized by a U.S. Government obligation; 1.88% due 2/28/27; valued at $731,554)     717,204 
       

Total Securities held as Collateral on Loaned Securities (Cost $19,962,185)

    19,962,185  

 

 

 

Morgan Stanley Insight Fund

Consolidated Portfolio of Investments ▪ September 30, 2022 (unaudited) continued

 

NUMBER OF
SHARES
(000)
            
     Investment Company (1.4%)          
 26,708   Morgan Stanley Institutional Liquidity Funds – Treasury Securities Portfolio - Institutional Class (f) (Cost $26,707,950)        26,707,950 
     Total Short-Term Investments (Cost $46,670,135)        46,670,135 
                
    

Total Investments Excluding Purchased Options

     (Cost $3,140,700,222)

   101.0%   1,884,803,297 
     Total Purchased Options Outstanding (Cost $12,466,894)   1.0%   17,271,099 
                
     Total Investments (Cost $3,153,167,116) Including $19,984,056 of Securities Loaned (g)(h)(i)(j)102.0%   1,902,074,396 
     Liabilities in Excess of Other Assets   (2.0)   (36,693,528)
     Net Assets    100.0%  $1,865,380,868 

  

 

ADR American Depositary Receipt.
(a) Non-income producing security.
(b) All or a portion of this security was on loan. The value of loaned securities and related collateral outstanding at September 30, 2022, were $19,984,056 and $20,353,857 respectively. The Fund received cash collateral of $20,237,290, of which $19,962,185 was subsequently invested in Repurchase Agreements and Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - Institutional Class as reported in the Consolidated Portfolio of Investments. At September 30, 2022, there was uninvested cash of $275,105. The remaining collateral of $116,567 was received in the form of U.S. Government obligations, which the Fund cannot sell or re-pledge and accordingly are not reflected in the Consolidated Portfolio of Investments. The Fund has the right under the securities lending agreement to recover the securities from the borrower on demand.
(c) Security cannot be offered for public resale without first being registered under the Securities Act of 1933 and related rules (“restricted security”). Acquisition date represents the day on which an enforceable right to acquire such security is obtained and is presented along with related cost in the security description. The Fund has registration rights for certain restricted securities. Any costs related to such registration are borne by the issuer. The aggregate value of restricted securities (excluding 144A holdings) at September 30, 2022 amounts to $46,342,607 and represents 2.5% of net assets.
(d) At September 30, 2022, the Fund held fair valued securities valued at $46,342,607, representing 2.5% of net assets. These securities have been fair valued as determined in good faith under procedures established by and under the general supervision of the Fund’s Trustees.
(e) Amount is less than 0.05%.
(f) The Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - (the “Liquidity Funds”), an open-end management investment company managed by the Adviser, both directly and as a portion of the securities held as collateral on loaned securities. Advisory fees paid by the Fund are reduced by an amount equal to its pro-rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Funds. For the nine months ended September 30, 2022, advisory fees paid were reduced by $45,978 relating to the Fund’s investment in the Liquidity Funds.
(g) The Fund is permitted to purchase and sell securities (“cross-trade”) from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Trustees in compliance with Rule 17a-7 under the Act (the “Rule”). Each cross-trade is executed at the current market price in compliance with provisions of the Rule. For the nine months ended September 30, 2022, the Fund did not engage in any cross-trade transactions.
(h) The fair value and percentage of net assets, $54,898,795 and 2.9%, respectively, represent the securities that have been fair valued under the fair valuation policy for international investments as described in the Notes to the Consolidated Portfolio of Investments.
(i) Securities are available for collateral in connection with purchased options.
(j) At September 30, 2022, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is $29,806,927and the aggregate gross unrealized depreciation is $1,280,899,647, resulting in net unrealized depreciation of $1,251,092,720.
   

 

 

 

Morgan Stanley Insight Fund

Consolidated Portfolio of Investments ▪ September 30, 2022 (unaudited) continued

 

Call Options Purchased: 

The Fund had the following call options purchased open at September 30, 2022:

 

Counterparty  Description  Strike
Price
  Expiration
Date
  Number of
Contracts
   Notional
Amount
(000)
   Value   Premiums
Paid
   Unrealized
Appreciation
 
JP Morgan Chase Bank NA  USD/CNH  CNH     7.53  Jul-23   456,541,099    456,541   $4,215,700   $2,266,727   $1,948,973 
Standard Chartered Bank  USD/CNH  CNH     7.57  Aug-23   488,704,358    488,704    4,499,990    2,181,576    2,318,414 
Goldman Sachs International  USD/CNH  CNH     7.27  Nov-22   1,670,325,800    1,670,326    8,555,409    8,018,591    536,818 
                      $17,271,099   $12,466,894   $4,804,205 

 

 

CNH Chinese Yuan Renminbi Offshore
USD United States Dollar
     

 

 

CONSOLIDATED SUMMARY OF INVESTMENTS  

 

INDUSTRY†  VALUE   PERCENTAGE
OF
TOTAL
INVESTMENTS
 
Information Technology Services  $450,521,964    23.9%
Software   407,459,489    21.7 
Internet & Direct Marketing Retail   193,576,278    10.3 
Road & Rail   132,539,294    7.0 
Health Care Providers & Services   131,181,585    7.0 
Pharmaceuticals   109,099,508    5.8 
Entertainment   107,485,108    5.7 
Health Care Technology   74,976,641    4.0 
Interactive Media & Services   48,179,457    2.6 
Investment Companies   40,241,990    2.2 
Semiconductors & Semiconductor Equipment   39,947,948    2.1 
Biotechnology   29,371,139    1.6 
Life Sciences Tools & Services   21,454,468    1.1 
Call Options Purchased   17,271,099    0.9 
Capital Markets   16,773,591    0.9 
Leisure Products   13,684,817    0.7 
Specialty Retail   12,230,344    0.6 
Chemicals   11,292,426    0.6 
Automobiles   10,176,759    0.5 
Electrical Equipment   5,761,397    0.3 
Commercial Services & Supplies   5,501,486    0.3 
Consumer Finance   3,385,423    0.2 
Electronic Equipment, Instruments & Components   ††   0.0 
Total Investments  $1,882,112,211    100.0%

 

 

Percentages indicated are based upon total investments (excluding Securities held as collateral on Loaned Securities) as of September 30, 2022.
†† Includes a security valued at zero.

  

 

 

Morgan Stanley Insight Fund

Notes to Consolidated Portfolio of Investments September 30, 2022 (unaudited)

 

Valuation of Investments - (1) An equity portfolio security listed or traded on an exchange is valued at its latest reported sales price (or at the exchange official closing price if such exchange reports an official closing price), and if there were no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant exchanges. If only bid prices are available then the latest bid price may be used. Listed equity securities not traded on the valuation date with no reported bid and asked prices available on the exchange are valued at the mean between the current bid and asked prices obtained from one or more reputable brokers/dealers. In cases where a security is traded on more than one exchange, the security is valued on the exchange designated as the primary market; (2) all other equity portfolio securities for which over-the-counter (“OTC”) market quotations are readily available are valued at the latest reported sales price (or at the market official closing price if such market reports an official closing price), and if there was no trading in the security on a given day and if there is no official closing price from relevant markets for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant markets. An unlisted equity security that does not trade on the valuation date and for which bid and asked prices from the relevant markets are unavailable is valued at the mean between the current bid and asked prices obtained from one or more reputable brokers/dealers; (3) when market quotations are not readily available, including circumstances under which Morgan Stanley Investment Management Inc. (the “Adviser”), a wholly-owned subsidiary of Morgan Stanley determines that the closing price, last sale price or the mean between the last reported bid and asked prices are not reflective of a security’s market value, portfolio securities are valued at their fair value as determined in good faith under procedures established by and under the general supervision of the Fund’s Board of Trustees (the “Trustees”). Occasionally, developments affecting the closing prices of securities and other assets may occur between the times at which valuations of such securities are determined (that is, close of the foreign market on which the securities trade) and the close of business on the New York Stock Exchange (“NYSE”). If developments occur during such periods that are expected to materially affect the value of such securities, such valuations may be adjusted to reflect the estimated fair value of such securities as of the close of the NYSE, as determined in good faith by the Trustees or by the Adviser using a pricing service and/or procedures approved by the Trustees; (4) foreign exchange transactions (“spot contracts”) and foreign exchange forward contracts (“forward contracts”) are valued daily using an independent pricing vendor at the spot and forward rates, respectively, as of the close of the NYSE; (5) listed options are valued at the last reported sales price on the exchange on which they are listed (or at the exchange official closing price if such exchange reports an official closing price). If an official closing price or last reported sales price is unavailable, the listed option should be fair valued at the mean between its latest bid and ask prices. Unlisted options are valued at the mean between their latest bid and ask prices from a broker/dealer or valued by a pricing service/vendor; (6) fixed income securities may be valued by an outside pricing service/vendor approved by the Trustees. The pricing service/vendor may employ a pricing model that takes into account, among other things, bids, yield spreads and/or other market data and specific security characteristics. If the Adviser, a wholly-owned subsidiary of Morgan Stanley, determines that the price provided by the outside pricing service/vendor or exchange does not reflect the security’s fair value or is unable to provide a price, prices from brokers/dealers may also be utilized. In these circumstances, the value of the security will be the mean of bid and asked prices obtained from brokers/dealers; and (7) investments in mutual funds, including the Morgan Stanley Institutional Liquidity Funds, are valued at the net asset value as of the close of each business day.

 

In connection with Rule 2a-5 of the Act, which became effective September 8, 2022, the Trustees have designated the Trust’s Adviser as its valuation designee. The valuation designee has responsibility for determining fair value and to make the actual calculations pursuant to the fair valuation methodologies previously approved by the Trustees. Under procedures approved by the Trustees, the Fund’s Adviser, as valuation designee, has formed a Valuation Committee whose members are approved by the Trustees. The Valuation Committee provides administration and oversight of the Fund’s valuation policies and procedures, which are reviewed at least annually by the Trustees. These procedures allow the Fund to utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.

 

 

 

 

Fair Valuation Measurements

 

Financial Accounting Standards Board (“FASB”) Accounting Standards CodificationTM (“ASC”) 820, “Fair Value Measurement” (“ASC 820"), defines fair value as the price that would be received to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-tier hierarchy to distinguish between (1) inputs that reflect the assumptions market participants would use in valuing an asset or liability developed based on market data obtained from sources independent of the reporting entity (observable inputs); and (2) inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in valuing an asset or liability developed based on the best information available in the circumstances (unobservable inputs) and to establish classification of fair value measurements for disclosure purposes. Various inputs are used in determining the value of the Fund’s investments. The inputs are summarized in the three broad levels listed below:

 

Level 1 – unadjusted quoted prices in active markets for identical investments

 

Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

 

Level 3 – significant unobservable inputs including the Fund’s own assumptions in determining the fair value of investments. Factors considered in making this determination may include, but are not limited to, information obtained by contacting the issuer, analysts, or the appropriate stock exchange (for exchange-traded securities), analysis of the issuer’s financial statements or other available documents and, if necessary, available information concerning other securities in similar circumstances.

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities and the determination of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each security.

 

 

 

 

The following is a summary of the inputs used to value the Fund’s investments as of September 30, 2022:

 

Investment Type  Level 1
Unadjusted
quoted
prices
   Level 2
Other
significant
observable
inputs
   Level 3
Significant
unobservable
inputs
   Total 
Assets:                    
Common Stocks                    
Automobiles  $10,176,759   $   $   $10,176,759 
Biotechnology   29,371,139            29,371,139 
Capital Markets   16,773,591            16,773,591 
Chemicals   11,044,809            11,044,809 
Commercial Services & Supplies   5,501,486            5,501,486 
Consumer Finance   3,385,423            3,385,423 
Electrical Equipment   5,761,397            5,761,397 
Electronic Equipment, Instruments & Components              
Entertainment   107,485,108            107,485,108 
Health Care Providers & Services   131,181,585            131,181,585 
Health Care Technology   74,976,641            74,976,641 
Information Technology Services   395,623,169    54,898,795        450,521,964 
Interactive Media & Services   48,179,457            48,179,457 
Internet & Direct Marketing Retail   193,576,278            193,576,278 
Leisure Products   13,684,817            13,684,817 
Life Sciences Tools & Services   21,454,468            21,454,468 
Pharmaceuticals   109,099,508            109,099,508 
Road & Rail   132,539,294            132,539,294 
Semiconductors & Semiconductor Equipment   39,947,948            39,947,948 
Software   361,116,882            361,116,882 
Specialty Retail   12,230,344            12,230,344 
Total Common Stocks   1,723,110,103    54,898,795       1,778,008,898
Warrant   247,617            247,617 
Preferred Stocks                    
Software           46,342,607    46,342,607 
Investment Company   13,534,040            13,534,040 
Call Options Purchased       17,271,099        17,271,099 
Short-Term Investments                    
Investment Company   43,562,250            43,562,250 
Repurchase Agreements       3,107,885        3,107,885 
Total Short-Term Investments   43,562,250    3,107,885        46,670,135 
Total Assets  $1,780,454,010   $75,277,779   $46,342,607  $1,902,074,396

 

Includes a security valued at zero.

 

Transfers between investment levels may occur as the markets fluctuate and/or the availability of data used in an investment’s valuation changes.

 

 

 

 

Following is a reconciliation of investments in which significant unobservable inputs (Level 3) were used in determining fair value:

 

   COMMON
STOCK
   PREFERRED
STOCKS
 
Beginning Balance  $-   $58,239,279
Purchases   -    - 
Sales   -    (1,890,433)
PIPE transactions   -    - 
Transfers in   -   - 
Transfers out   -     (-)†
Corporate actions   -    - 
Change in unrealized appreciation (depreciation)   -    (10,006,239)
Realized gains (losses)   -    - 
Ending Balance  $    -   $46,342,607 
           
Net change in unrealized appreciation (depreciation) from investments still held as of September 30, 2022  $-   $(10,006,239)

 

Includes a security valued at zero.    

 

 

 

The following table presents additional information about valuation techniques and inputs used for investments that are measured at fair value and categorized within Level 3 as of September 30, 2022. Various valuation techniques were used in the valuation of certain investments and weighted based on the level of significance. The Fund calculated the weighted averages of the unobservable inputs relative to each investment’s fair value as of September 30, 2022.

 

   Fair Value at
September 30, 2022
   Valuation
Technique
  Unobservable
Input
  Amount or Range
/Weighted Average*
   Impact to
Valuation from an
Increase In Input**
Preferred Stocks  $46,342,607   Discounted Cash Flow  Weighted Average
Cost of Capital
  12.5% - 14.5% / 13.5%   Decrease
           Perpetual Growth
Rate
  3.0% - 4.0% / 3.5%   Increase
        Market Comparable
Companies
  Enterprise Value
/Revenue
  1.1x - 26.3x / 22.5x   Increase
           Discount for Lack
of Marketability
  12.0% - 14.0% / 14.0%   Decrease
        Comparable Transactions  Enterprise Value
/Revenue
  9.3x  Increase

 

 

* Amount is indicative of the weighted average.
** Represents the expected directional change in the fair value of the Level 3 investments that would result from an increase in the corresponding input.
A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs could result in significantly higher or lower fair value measurements.